SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (22459)6/18/1998 9:43:00 AM
From: Phil Cressman  Read Replies (1) | Respond to of 32384
 
This must just be administrative. Was it not the end of the year before the FDA approval for ONTAC was expected. It will no doubt take some time to provide all required documentation on the plant, proposed labeling, instructions etc. etc. , which must be if front of the FDA before they will grant the approval. This must have all been known to Ligand/SRGN and it would be nice for them to inform us all so that those nervous types don't trade the stock out at less than the market should be.



To: Henry Niman who wrote (22459)6/18/1998 9:56:00 AM
From: Flagrante Delictu  Respond to of 32384
 
Henry, The plant is already a GMP approved plant producing compounds for other pharmas. I wondered why LGND had a clause in the SRGN deal that required FDA approval within 2 years. Maybe they suspected some sort of delay.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News